NTRK1 and neoplasm: Mechanistic studies implicate neurotrophin and axon−guidance signaling (e.g., GDNF–RET, NGF–TrkA) and Schwann−cell reprogramming as drivers of neural tracking and extracellular−matrix remodeling at the nerve–tumor interface (85–87).